History
  • No items yet
midpage
In re Gentiva Securities Litigation
2013 U.S. Dist. LEXIS 42102
E.D.N.Y
2013
Read the full case

Background

  • Consolidated securities fraud class action on Gentiva investors from July 31, 2008 to October 4, 2011; defendants moved to dismiss, granted.
  • Gentiva provided home health services under Medicare’s HH PPS; payments tied to physician plans of care, OASIS data, and case-mix classifications.
  • Care was allegedly driven by threshold-based Medicare bonuses (6, 14, or 20 visits) and recertification for additional episodes, affecting revenue.
  • Plaintiffs rely on confidential witnesses describing management pressure to increase visits and to upcode or otherwise inflate Medicare reimbursements.
  • Two identified witnesses (McComas, Shah) described coding and pressure dynamics; multiple CWs described systemic pressure across regions.
  • SFC and SEC investigations (2010-2011) and the SFC Report alleged shifts in patient visits following threshold changes; internal emails discussed maximizing reimbursements.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Section 10(b)/Rule 10b-5 claim viability Plaintiff asserts misstatements/omissions and scienter based on Medicare billing pressures. Defendants argue no actionable misstatements with particularity; many claims are puffery or non-actionable. 10(b) claims survive only with specific scienter; court grants dismissal for lack of strong inference.
Scienter sufficiency under PSLRA Plaintiff contends internal emails and CWs show knowledge or reckless disregard. Defendants contend CWs insufficiently link to executives; emails do not prove intentional falsehoods. Court finds no strong inference of scienter; holistic view insufficient to meet PSLRA standard.
Section 20(a) control person liability Corporate officers’ control and participation could render Gentiva liable. If primary 10(b) claim fails, control person liability should fail; scienter lacking. Section 20(a) claim dismissed.
Section 11 standing and merits (1933 Act) for the Offering LACERS has standing to pursue Section 11 on the bond offering; injury can be traced. LACERS lacks direct purchase of 11.5% notes; standing problem; misstatements contested. Lead Plaintiff lacks standing; Section 11 claims dismissed with prejudice; time-bar and damages issues noted.
Section 11 substantive viability (fraud vs negligence under 1933 Act) Allegations resemble 10(b) fraud; Section 11 sounds in fraud; Rule 9(b) implications. Fraud-oriented pleading not properly separated; negligence/strict liability not adequately pled. Section 11 sounds in fraud; Rule 9(b) not satisfied; dismissal with prejudice.

Key Cases Cited

  • Tellabs, Inc. v. Makor Issues & Rights, 551 U.S. 308 (U.S. 2007) (strong inference of scienter standard; holistic view required)
  • Slayton v. American Express Co., 604 F.3d 758 (2d Cir. 2010) (heightened PSLRA pleading; well-pled facts required)
  • Ganino v. Citizens Utilities Co., 228 F.3d 154 (2d Cir. 2000) (materiality assessed in light of total financial picture)
  • In re CitiGroup Inc. Secs. Litig., 723 F. Supp. 2d 568 (S.D.N.Y. 2010) (statements must be timely and specific; historical facts used)
  • In re Wachovia Equity Sec. Litig., 753 F. Supp. 2d 344 (S.D.N.Y. 2010) (Confidential witnesses require particularity; holistic view)
Read the full case

Case Details

Case Name: In re Gentiva Securities Litigation
Court Name: District Court, E.D. New York
Date Published: Mar 25, 2013
Citation: 2013 U.S. Dist. LEXIS 42102
Docket Number: No. 10-cv-5064 (ADS)(WDW)
Court Abbreviation: E.D.N.Y